Epia Neuro
PrivateLast Round
Early Funding
Apr 1, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Epia Neuro is a neurotechnology company that is building a minimally invasive brain-computer interface platform that detects neural intent and restores motor control for stroke survivors and patients with cognitive decline.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Sensors
Business Model
B2B2C
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Epia Neuro Comparables
Compare Epia Neuro with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kandu Health | 81% | |
| Precision Neuroscience | 77% | |
| Neuracle | 77% | |
Epia Neuro Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Apr 1, 2026 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Raised an early funding round with participation from cgf2021-llc.
Epia Neuro Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Epia Neuro's valuation, stock price, and market status.